Fiurik 300mg Tablet
Product Info
Prescription required | Yes |
Marketer | Garwyn Remedies |
Active Ingredient | Allopurinol (300mg) |
Storage | Store below 30°C |
Chemical Class | Pyrazolo Pyrimidine Derivative |
Habit Forming | No |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Xanthine oxidase Inhibitors-gout |
User Rating | 4.6 |
User Reviews | 451 |
FAQ
Fiurik 300mg Tablet Reviews
Fiurik 300mg should be taken after food. You should keep taking it as recommended by your doctor even when you are not having a gout attack. If you stop, your symptoms may get worse because more crystals form in your joints and kidneys. You can help yourself by making some changes to your diet and drinking plenty of fluids.
Some of the common side effects of this medicine are nausea, diarrhea, increased serum glutamic oxaloacetic transaminase and serum glutamate pyruvate transaminase, and increased alkaline phosphatase. Your doctor may help with ways to reduce or prevent these symptoms. Some people may get a severe allergic reaction that needs urgent medical attention. Talk to your doctor straight away if you get symptoms of liver disease including nausea that does not stop, yellowing skin or eyes, or dark urine.
To make sure it is safe for you, before taking this medicine, let your doctor know if you have or have had heart failure, heart problems, stroke, kidney or liver disease, or thyroid problems. Do not use this medicine if you are pregnant or breastfeeding. Check with your doctor. You will be asked for regular blood tests to check that your liver is working properly.
How Fiurik 300mg Tablet Works
How to Use Fiurik 300mg Tablet
Benefits of Fiurik 300mg Tablet
- In Treatment of Gout: Fiurik 300mg is used to prevent and treat gout. Gout is caused by too much uric acid in your body. When the level becomes too high, crystals may form in and around certain joints and your kidneys. This can cause sudden and severe pain, redness, warmth, and swelling. This medicine works by preventing crystals from forming and reducing the levels of uric acid in your blood. This makes it less likely that you will suffer the symptoms and make them milder if you do have them. It is usually for long-term treatment and should be taken regularly until the dose is completed.
Uses of Fiurik 300mg Tablet
- Treatment of Gout
Fiurik 300mg Tablet Side Effects
Safety Tips
Quick Tips
- Your doctor has prescribed Fiurik 300mg to reduce episodes of gout attack.
- Your doctor may check your liver function before starting treatment and regularly thereafter. Inform your doctor if you notice yellowing of eyes or skin, dark urine, or stomach pain.
- Do not consume alcohol while taking this medicine as it may cause your gout to flare up.
- When you first start taking this medicine, you might have more gout attacks. Do not stop Fiurik 300mg on having an acute attack of gout as that could make an attack worse.
- Take Fiurik 300mg with food to avoid stomach upset.
- Notify your doctor if you develop a rash. This could be a sign of allergy and should go away on discontinuing Fiurik 300mg.
- Take plenty of fluids (2-3 litres) daily while on Fiurik 300mg.
References
- Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 996-97.
- CiplaMed. Allopurinol [Prescribing Information].
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198.
- Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 638-39.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 40-42.